Fresenius Medical Care AGFMS财报
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
FMS Q4 2025 Key Financial Metrics
营收
$5.5B
毛利润
$1.5B
营业利润
$641.4M
净利润
$434.2M
毛利率
27.4%
营业利润率
11.7%
净利率
7.9%
同比增长
-0.3%
资金流向
Fresenius Medical Care AG Q4 2025 财务摘要
Fresenius Medical Care AG reported revenue of $5.5B (down 0.3% YoY) for Q4 2025, with a net profit of $434.2M (up 240.4% YoY) (7.9% margin). Cost of goods sold was $4.0B, operating expenses totaled $858.1M.
核心财务指标
| 总营收 | $5.5B |
|---|---|
| 净利润 | $434.2M |
| 毛利率 | 27.4% |
| 营业利润率 | 11.7% |
| 报告期 | Q4 2025 |
Fresenius Medical Care AG 季度营收与净利润历史
Fresenius Medical Care AG quarterly results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $5.5B | -0.3% | $434.2M | 7.9% |
| Q4 2024 | $5.5B | +1.9% | $127.6M | 2.3% |
利润表
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 营收 | $5.49B | $5.48B |
| 同比增长 | 1.9% | -0.3% |
资产负债表
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 总资产 | $36.25B | $33.48B |
| 总负债 | $19.22B | $18.06B |
| 股东权益 | $17.03B | $15.43B |
现金流量表
| Q4 2024 | Q4 2025 | |
|---|---|---|
| 经营性现金流 | $2.58B | $2.90B |